| Revenues from Contracts with Customers |
REVENUES FROM CONTRACTS WITH CUSTOMERS Disaggregation of Revenue from Contracts with Customers—The disaggregation of revenue by segment and product is depicted for the periods presented below, and is consistent with how the Company evaluates its financial performance:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended March 31, | | Nine Months Ended March 31, | | (in thousands) | | 2024 | | 2023 | | 2024 | | 2023 | | Senior: | | | | | | | | | | Commission revenue: | | | | | | | | | | Medicare advantage | | $ | 184,740 | | | $ | 156,014 | | | $ | 477,081 | | | $ | 412,850 | | | Medicare supplement | | 1,027 | | | 417 | | | 2,965 | | | 1,588 | | | Prescription drug plan | | 324 | | | 203 | | | 697 | | | 481 | | | Dental, vision, and health | | 845 | | | 1,185 | | | 2,599 | | | 3,203 | | | Other commission revenue | | 588 | | | 726 | | | 1,361 | | | 2,162 | | | Total commission revenue | | 187,524 | | | 158,545 | | | 484,703 | | | 420,284 | | | | | | | | | | | | Total other revenue | | 16,735 | | | 26,655 | | | 57,002 | | | 66,257 | | | Total Senior revenue | | 204,259 | | | 185,200 | | | 541,705 | | | 486,541 | | | Healthcare Services: | | | | | | | | | | Total pharmacy revenue | | 120,282 | | | 66,948 | | | 323,865 | | | 159,641 | | | Total other revenue | | 3,925 | | | 3,777 | | | 9,419 | | | 9,629 | | | Total Healthcare Services revenue | | 124,207 | | | 70,725 | | | 333,284 | | | 169,270 | | | Life: | | | | | | | | | | Commission revenue: | | | | | | | | | | Term | | 17,789 | | | 17,678 | | | 55,016 | | | 49,371 | | | Final expense | | 17,537 | | | 13,804 | | | 46,139 | | | 44,357 | | | Total commission revenue | | 35,326 | | | 31,482 | | | 101,155 | | | 93,728 | | | | | | | | | | | | Total other revenue | | 5,360 | | | 5,468 | | | 14,700 | | | 14,052 | | | Total Life revenue | | 40,686 | | | 36,950 | | | 115,855 | | | 107,780 | | | Auto & Home: | | | | | | | | | | Total commission revenue | | 8,746 | | | 7,895 | | | 27,836 | | | 21,940 | | | | | | | | | | | | Total other revenue | | 388 | | | 343 | | | 813 | | | 1,188 | | | Total Auto & Home revenue | | 9,134 | | | 8,238 | | | 28,649 | | | 23,128 | | | Eliminations: | | | | | | | | | | Total commission revenue | | (833) | | | (664) | | | (1,950) | | | (2,325) | | | | | | | | | | | | Total other revenue | | (1,053) | | | (1,051) | | | (2,976) | | | (3,324) | | | Total Elimination revenue | | (1,886) | | | (1,715) | | | (4,926) | | | (5,649) | | | Total commission revenue | | 230,763 | | | 197,258 | | | 611,744 | | | 533,627 | | | | | | | | | | | | Total pharmacy revenue | | 120,282 | | | 66,948 | | | 323,865 | | | 159,641 | | | Total other revenue | | 25,355 | | | 35,192 | | | 78,958 | | | 87,802 | | | Total revenue | | $ | 376,400 | | | $ | 299,398 | | | $ | 1,014,567 | | | $ | 781,070 | |
Contract Balances—The Company has contract assets related to commissions receivable from its insurance carrier partners, with the movement over time as the policy is renewed between long-term and short-term commissions receivable and accounts receivable, net being the main activity, along with commission revenue adjustments from changes in estimates.
A roll forward of commissions receivable (current and long-term) is shown below for the period presented:
| | | | | | | | | | | | | (in thousands) | | | | | | Balance as of June 30, 2023 | | $ | 840,498 | | | | | | Commission revenue from revenue recognized | | 218,136 | | | | | | Net commission revenue adjustment from change in estimate | | 1,667 | | | | | | Amounts recognized as accounts receivable, net | | (227,178) | | | | | Balance as of March 31, 2024 | | $ | 833,123 | | | | |
For the nine months ended March 31, 2024, the $1.7 million net commission revenue adjustment from change in estimate includes adjustments related to revenue recognized in prior fiscal years, based on the Company’s reassessment of each of its cohorts’ transaction prices. It includes a negative adjustment of $1.8 million for Senior, a positive adjustment of $3.4 million for Auto & Home, and a positive adjustment of $0.1 million for Life.
The Company’s contract liabilities on the condensed consolidated balance sheets represent unamortized upfront payments received as of March 31, 2024, for commission revenue for which the performance obligations have not yet been met and are anticipated to be recognized over the next twelve months.
A roll forward of contract liabilities (current and long-term) is shown below for the period presented:
| | | | | | | | | | (in thousands) | | | Balance as of June 30, 2023 | | $ | 1,691 | | Commission revenue recognized | | (27,241) | | Other revenue recognized | | (515) | | | Amounts recognized as contract liabilities | | 29,720 | | Balance as of March 31, 2024 | | $ | 3,655 | |
|